Cell Therapy

News

Changes ring at Oxford Bio as ABL takeover talks progress

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europ

News

FDA capacity forces delay to Iovance's cell therapy

Iovance Biotherapeutics is facing a three-month delay in the review of its lifileucel cell therapy for melanoma in the US, held up by "insufficient resources" at the FDA.

Oncology

CAR-TCR 2023 – Greg Deener

In late August, pharmaphorum traveled to Boston to cover CAR-TCR, a conference dedicated to the fast-moving cell therapy space.

Oncology

Five takeaways from the CAR-TCR cell therapy conference

Last week, I had the privilege of heading into town in Boston to attend three days of the CAR-TCR conference, a major annual gathering of researchers and industry stakeholders concerned wit

News

BlueRock clears key hurdle in Parkinson's stem cell trial

It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel, with no major safety issues reported after a y

News

Aspen taps tech firms for digital Parkinson's trial

Aspen Neuroscience is adding a digital dimension to a study of its experimental cell therapy for Parkinson's disease, with the help of tech companies Emerald Innovations a

Changes ring at Oxford Bio as ABL takeover talks progress

FDA capacity forces delay to Iovance's cell therapy

CAR-TCR 2023 – Greg Deener

Five takeaways from the CAR-TCR cell therapy conference

BlueRock clears key hurdle in Parkinson's stem cell trial

Aspen taps tech firms for digital Parkinson's trial

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Cell Therapy

Editor's Picks